Rare diseases
Investigational molecules
Locations
Back to France3 418 clinical trials in Le Kremlin-Bicetre, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study of Olaparib for Patients with Advanced Cancer Having HRRm or HRD Mutations
FranceStudy on the Safety and Effectiveness of Sacituzumab Govitecan for Patients with Triple Negative Metastatic Breast Cancer
FranceStudy on the Safety and Effectiveness of CGT9486 for Patients with Nonadvanced Systemic Mastocytosis
FranceStudy on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months
FranceFranceStudy on Botensilimab Alone and with Balstilimab or Drug Combination for Patients with Refractory Metastatic Colorectal Cancer
FranceStudy on UCART20x22 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma Using a Drug Combination
FranceStudy on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
FranceStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
FranceStudy on Imlifidase and Drug Combination for Treating Severe Goodpasture Disease in Patients
FranceStudy on the Effectiveness of High-Dose Vitamin C for Patients with Shock After Cardiac Arrest
FranceStudy on Surgery with or without Darolutamide for Patients with High-Risk or Locally Advanced Prostate Cancer
FranceThe busiest research cities in the country
What the registry says about research in the country
Research in this area focuses on bacterial infections, especially severe ear, nose and throat diseases such as idiopathic purulent oedematous sinusitis in adults. The trials are aimed at evaluating whether treatment can improve symptoms and overall patient well-being.
In Kremlin Bicêtre, this work reflects a practical effort to better manage chronic ENT infection-related complaints.
Clinical research here also covers cardiovascular disease in patients hospitalized for septic shock with tachycardia and hypercontractility. The main goal is to evaluate whether controlling heart rate may help improve survival and clinical outcomes.
These trials are designed to clarify whether better cardiovascular support can reduce risk in critically ill patients.
Another key research focus is otorhinolaryngology, with attention on sinusitis and related ENT disorders. The studies are looking at treatment effectiveness and changes in patient-reported symptoms during follow-up.
This area highlights efforts to improve everyday functioning for patients living with ongoing nasal and sinus problems.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
